tiprankstipranks
Replimune Group Inc (REPL)
NASDAQ:REPL
Want to see REPL full AI Analyst Report?

Compare Replimune Group (REPL) vs. Competitors

592 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Replimune Group
$15.80
$1.39B
-4.59
148.28%
7 Buy
0 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$3.37
$795.33M
-7.87
69.38%
4 Buy
0 Hold
0 Sell
Strong Buy
Immatics
$9.43
$1.41B
-4.92
57.34%
5 Buy
0 Hold
0 Sell
Strong Buy
Lyell Immunopharma
$15.49
$331.55M
-0.80
-2.05%
4 Buy
0 Hold
1 Sell
Moderate Buy
Candel Therapeutics
$13.28
$964.13M
-8.63
144.87%
5 Buy
1 Hold
0 Sell
Strong Buy
Artiva Biotherapeutics, Inc.
$11.77
$531.92M
-3.26
288.13%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
REPL
Replimune Group
14.45
8.46
141.24%
CTMX
CytomX Therapeutics
3.54
1.47
71.01%
IMTX
Immatics
9.11
3.30
56.80%
LYEL
Lyell Immunopharma
12.88
-0.19
-1.45%
CADL
Candel Therapeutics
12.17
7.32
150.93%
ARTV
Artiva Biotherapeutics, Inc.
10.79
8.09
299.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts